Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for Core Scientific (CORZ) over the last 5 years, with Dec 2024 value amounting to $134.6 million.

  • Core Scientific's Total Current Liabilities rose 775.48% to $669.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $669.9 million, marking a year-over-year increase of 775.48%. This contributed to the annual value of $134.6 million for FY2024, which is 72.45% down from last year.
  • Core Scientific's Total Current Liabilities amounted to $134.6 million in FY2024, which was down 72.45% from $488.4 million recorded in FY2023.
  • Core Scientific's 5-year Total Current Liabilities high stood at $488.4 million for FY2023, and its period low was $400 during FY2020.
  • In the last 3 years, Core Scientific's Total Current Liabilities had a median value of $186.8 million in 2022 and averaged $269.9 million.
  • Per our database at Business Quant, Core Scientific's Total Current Liabilities soared by 80,072,150.00% in 2021 and then slumped by 72.45% in 2024.
  • Core Scientific's Total Current Liabilities (Yearly) stood at $400 in 2020, then skyrocketed by 80,072,150.00% to $320.3 million in 2021, then slumped by 41.68% to $186.8 million in 2022, then spiked by 161.48% to $488.4 million in 2023, then tumbled by 72.45% to $134.6 million in 2024.